These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26272410)

  • 1. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.
    Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
    Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.
    Katz LH; Advani S; Burton-Chase AM; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
    Fam Cancer; 2017 Apr; 16(2):231-237. PubMed ID: 27832499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review.
    Nugroho PP; Ghozali SAS; Buchanan DD; Pisano MI; Reece JC
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):25-46. PubMed ID: 36251064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.
    Patel SG; Ahnen DJ; Kinney AY; Horick N; Finkelstein DM; Hill DA; Lindor NM; MaCrae F; Lowery JT
    Am J Gastroenterol; 2016 Feb; 111(2):285-93. PubMed ID: 26856748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
    Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB
    Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey.
    Barrow P; Green K; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2015 Jun; 87(6):517-24. PubMed ID: 25652327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
    Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
    J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
    Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
    Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.
    Cragun D; Malo TL; Pal T; Shibata D; Vadaparampil ST
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):493-9. PubMed ID: 22224634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers.
    Burton-Chase AM; Parker WM; Polivka KM; Gritz ER; Amos CI; Lu KH; Lynch PM; Rodriguez-Bigas MA; Nancy You Y; Peterson SK
    Cancer Med; 2017 Mar; 6(3):698-707. PubMed ID: 28211618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.
    Burton-Chase AM; Hovick SR; Peterson SK; Marani SK; Vernon SW; Amos CI; Frazier ML; Lynch PM; Gritz ER
    Clin Genet; 2013 Mar; 83(3):215-20. PubMed ID: 23414081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
    Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
    Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
    Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
    Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.
    Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H
    Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.